Clinical trials for needle free vaccine patches are set to begin mid next year, led by an Australian biotech firm.
Vaxxas, a Brisbane based biotechnology company hopes the technology can boost Australia’s future vaccination rollout.
The clinical trials follow successful animal studies conducted by the University of Queensland in partnership with Vaxxas.
UQ's Dr David Muller says "the research shows a strong and effective immune response".